Lower Urinary Tract Symptoms: all 412 studies

Page 4 of 5. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• Effect of Motor Cortex Versus Sacral Magnetic Stimulation in Multiple Sclerosis Patients With Urinary Tract DysfunctionCompletedNCT03434873Not applicable
• Prostatic Obstruction Investigation Team Multicenter StudyStatus unknownNCT03394651
• Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy ChildrenCompletedNCT03339609
• Can Women Correctly Contract Their Pelvic Floor Muscles After to Receive Verbal Instructions and Vaginal Palpation?CompletedNCT03325543Not applicable
• Environmental Factors to Increase Patient Comfort During Urodynamics TestingCompletedNCT03317340
• Effect of Need to Void on Parkinsonian GaitCompletedNCT03314610
• Best Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle ContractionCompletedNCT03272386
• Filling and Emptying Cystometries ("Backwards Cystometry"): a Feasibility and Validation StudyCompletedNCT03255421
• Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder DiaryCompletedNCT03249987Not applicable
• Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic HyperplasiaStatus unknownNCT03239652Not applicable
• ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPHCompletedNCT03230721Not applicable
• Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot StudyCompletedNCT03228485
• Effect of Need to Void on Gait Speed in Multiple SclerosisCompletedNCT03204747
• Impact of Lower Urinary Tract Dysfunction on Clinical Manifestation in Patients With StrokeCompletedNCT03174600
• Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate CancerCompletedNCT03104907Not applicable
• Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinenceActive, not recruitingNCT03104517Phase 3
• Prostatic Artery Embolization for Benign Prostatic ObstructionCompletedNCT03099421Not applicable
• Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in MenWithdrawnNCT03043222Not applicable
• Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPHCompletedNCT02972268Phase 3
• Impact of Tunneling During Minimally Invasive SacrocolpopexyCompletedNCT02856217Not applicable
• ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).Status unknownNCT02849522
• Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)Status unknownNCT02808013Phase 2
• Urological Biofeedback Game SoftwareCompletedNCT02758938Not applicable
• Urodynamic Testing: Can we Improve Patient Experience?CompletedNCT02742389Not applicable
• Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
• Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)TerminatedNCT02676544Phase 1/2
• EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
• The Association Between Ovarian Endometrioma and Lower Urinary Tract SymptomsStatus unknownNCT02623244
• A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)CompletedNCT02618421
• Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic HyperplasiaStatus unknownNCT02592473Not applicable
• Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract DysfunctionCompletedNCT02554201Not applicable
• Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesCompletedNCT02542501
• The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.CompletedNCT02494349Phase 1
• Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III HysterectomyStatus unknownNCT02492542Not applicable
• Symptoms of Lower Urinary Tract Dysfunction Phenotyping StudyCompletedNCT02485808
• UK ROPE Register StudyCompletedNCT02434575
• Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)CompletedNCT02410135
• TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTCompletedNCT02366975Phase 4
• HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPHCompletedNCT02332538Not applicable
• Auriculotherapy on Lower Urinary Tract Symptoms in Elderly MenCompletedNCT02330107Not applicable
• A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT02326454Phase 2
• Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract FunctionCompletedNCT02272309Not applicable
• The Effect and Safety of Moxibustion Therapy for Overactive Bladder PatientsCompletedNCT02271607Not applicable
• Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract SymptomsCompletedNCT02252367Phase 4
• The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)CompletedNCT02245542
• Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary SymptomsCompletedNCT02245490Phase 4
• Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding SymptomsCompletedNCT02244281Phase 2
• Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment MethodsStatus unknownNCT02193451Not applicable
• A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional FormulationCompletedNCT02180789Phase 4
• Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract SymptomsStatus unknownNCT02178761Not applicable
• The Effect of Diuresis During 20-minute Pad Test on the Estimation of the Severity of Stress Urinary IncontinenceStatus unknownNCT02126618
• Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic HyperplasiaCompletedNCT02074644Not applicable
• Electronic Method for Recording Lower Urinary Tract SymptomsCompletedNCT02060136
• Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot StudyCompletedNCT02051036Not applicable
• Reliability of Home Uroflowmetery Using a Disposable Digital DeviceStatus unknownNCT02026674Not applicable
• Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPHTerminatedNCT02003742Phase 3
• Lower Urinary Tract Symptoms in Systemic SclerosisCompletedNCT01971294
• Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPHCompletedNCT01966614Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.CompletedNCT01963312Not applicable
• Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract SymptomsCompletedNCT01939756Phase 1/2
• Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaCompletedNCT01939184Phase 2
• Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedNCT01922375Phase 4
• Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.CompletedNCT01884753
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)CompletedNCT01846793Phase 3
• The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic DisorderCompletedNCT01822288Phase 4
• Effect of Enhanced External Counterpulsation on Lower Urinary Tract SymptomsStatus unknownNCT01815697Not applicable
• Diclofenac Suppository to Control Pain During Flexible CystoscopyCompletedNCT01812928Phase 2
• The Association of Pelvic Organ Prolapse Severity and Urinary Symptoms and Sexual FunctionStatus unknownNCT01776580
• Microbiomes of Pelvic PainCompletedNCT01738464
• Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine SystemsCompletedNCT01730300
• Studies of Biomarkers in Female Lower Urinary Tract SymptomsStatus unknownNCT01681784
• Vesitirim™ in Men Postmarketing Observational StudyCompletedNCT01639794
• Lower Urinary Tract Symptoms Screening QuestionnaireCompletedNCT01616810
• Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single SurgeonCompletedNCT01604148
• Population-based Estimates of Medical Comorbidities in Women With Lower Urinary Tract Symptoms or Pelvic Organ ProlapseCompletedNCT01590576
• Group Versus Individual Urotherapy for ChildrenCompletedNCT01570673Not applicable
• BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)WithdrawnNCT01520441Early Phase 1
• Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT01454349Phase 1/2
• Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.CompletedNCT01282840Not applicable
• Study of Psychiatric Aspects in Women With Lower Urinary Tract SymptomsCompletedNCT01277029
• Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPHCompletedNCT01260129Phase 4
• Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With StrokeCompletedNCT01042249Not applicable
• Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002664Phase 3
• MCS in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002417Phase 2/3
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002274Phase 3
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)CompletedNCT01002222Phase 3
• Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00918034Phase 2
• Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic HyperplasiaCompletedNCT00908427Not applicable
• Efficacy Study of HoLEP and TURP on LUTS Secondary to BPHCompletedNCT00877669Phase 2
• Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract SymptomsWithdrawnNCT00870376
• Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for BrachytherapyCompletedNCT00866554Phase 2
• Evaluation of Symptom-specific Goal AchievementCompletedNCT00836823Phase 4
• Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)TerminatedNCT00743184Phase 2
• Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00709488Phase 1
• Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and HypertensionCompletedNCT00693199Not applicable
• Botulinum Toxin Injection With Prostate BrachytherapyWithdrawnNCT00681148Phase 2
• Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal DisordersCompletedNCT00667550
• Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling PhaseStatus unknownNCT00628615
• Prevalence of Lower Urinary Tract Symptoms in Women With Gynecologic Malignancy Planning to Undergo Surgical ManagementWithdrawnNCT00580697
• Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality StudyCompletedNCT00575913Phase 4

← Lower Urinary Tract Symptoms overview